What one share of Cocrystal Pharma holds
Cocrystal Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.76 |
|---|---|
| Cash and investments | $0.16 |
| Book value | $0.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | — | −$4.77 | $0.01 | −$2.64 | — | $4.86 |
| 2023 | — | −$1.86 | $0.01 | −$1.53 | — | $2.59 |
| 2024 | — | −$1.72 | $0.00 | −$1.62 | — | $0.94 |
| 2025 | — | −$0.78 | $0.00 | −$0.73 | — | $0.46 |
Common questions about Cocrystal Pharma
How much does one share of Cocrystal Pharma earn?
Over the last 12 months, Cocrystal Pharma lost $0.76 for each share.
Does Cocrystal Pharma pay a dividend?
Cocrystal Pharma didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cocrystal Pharma’s book value per share?
Cocrystal Pharma’s book value is $0.08 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Cocrystal Pharma have?
Each share of Cocrystal Pharma has $0.16 of cash and investments, as of June 30, 2026.
Has Cocrystal Pharma bought back shares?
Cocrystal Pharma’s share count rose about 39% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.